Get AG1
Sign In

Test staging

Abc 222 new text

v53

v53 test

QUALITY SOURCING

Farm to Label

We’ve always been dedicated to rigorous testing, third-party certifications, and strict sourcing standards. Now, we’re taking it a step further by creating visibility between our direct ingredients and the partners and farmers that enable our high quality and purity standards.

Citrus Bioflavonoids

Central Valley, California

Ingredient #51 of 75: citrus bioflavonoids from citrus proudly grown in sunny Fresno, California. AG1 takes the concentrated and potent extract of citrus bioflavonoids isolated from the most powerful – but often under-appreciated – part of the fruit: the peel. Supporting immune defense, citrus bioflavonoids are just one of the many high quality ingredients packed into every serving of AG1.

Test

Body

SHOP

LEARN MORE

ABOUT

CONTACT

Connect

Join Our Newsletter

© 2025 AG1

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Information on the AG1 site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular health care provider.

** Offer valid for first time subscribers only.

Actual Packaging May Vary

  1. In a triple-blind, randomized, placebo-controlled parallel-designed clinical trial evaluating nutrient biomarkers and microbiome shifts in 105 healthy adults ages 20-59 over the course of 12 weeks.
  2. In a double-blind, randomized, placebo-controlled 2-week crossover clinical trial assessing nutrient gaps and microbiome shifts in 20 active adults ages 19-37.
  3. In a double-blind, randomized, placebo-controlled 2-week crossover clinical trial assessing nutrient gaps and microbiome assessments of 40 healthy adults with occasional GI distress ages 26-59 over the course of 4 weeks.
  4. In a double-blind, randomized, placebo-controlled crossover clinical trial assessing nutrient gaps and bioavailability in 16 healthy adults ages 18-42 over the course of 8 hours.
  5. In a third-party, single-arm, closed label interventional study of 104 healthy adults ages 25-9 assessing self-perceived efficacy of AG1 Next Gen over 3 months.

Your privacy is our priority. Learn more:  

© 2025 AG1